Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Kaarniranta K et al. |
A mouse model for Stickler's syndrome: Ocular phenotype of mice carrying a targeted heterozygous inactivation of type II (pro)collagen gene (Col2al).
|
|
2 |
Kajander S. |
Sairaanhoitajaopiskelijan ohjaus ohjatussa harjoittelussa.
|
|
3 |
Kinnunen K et al. |
Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.
|
|
4 |
Määttä M et al. |
Immunolocalization of EMMPRIN (Cd147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids.
|
|
5 |
Pietilä J et al. |
Bilateral comparison of corneal flap dimensions with the Moria M2 reusable head and single use head microkeratomes.
|
|
6 |
Plantinga RF et al. |
Visual impairment in Finnish Usher syndrome type III.
|
|
7 |
Puustjärvi T et al. |
Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye.
|
|
8 |
Rekonen P et al. |
Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma.
|
|
9 |
Seitsonen S et al. |
Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population.
|
|
10 |
Simunaniemi T et al. |
Nivelreumapotilaat ongelmaryhmä sarveiskalvon siirroissa. Kuopion yliopistollisen sairaalan tulokset 10 vuodelta.
|
|
11 |
Tenhunen J, Teräsvirta M. |
Silmäpuudutukset.
|
|
12 |
Teräsvirta M et al. |
Syvä sklerektomia glaukooman kirurgisena hoitona.
|
|
13 |
Uusitalo H et al. |
Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma.
|